Future for Epigenetic Breast Tumor Risk Screening

Future for Epigenetic Breast Tumor Risk Screening

Genome Profiling CSO Adam Marsh considers the current potential of epigenetic screening tests for breast tumors in his Huffington Post essay “New Approaches for Breast Tumor Diagnostics”. Several recent medical studies indicate that epigenetic profiling of breast tumors may explain and predict how and why different women develop different types of breast tumors. These tumors are variable in their growth rates, response to therapeutics and invasiveness. Epigenetics is beginning to provide a quantifiable measure of how to differentiate these patient risk groups and tumor types.